304 related articles for article (PubMed ID: 33130550)
1. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19.
Yekedüz E; Utkan G; Ürün Y
Eur J Cancer; 2020 Dec; 141():92-104. PubMed ID: 33130550
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
[TBL] [Abstract][Full Text] [Related]
3. Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data.
Park R; Lee SA; Kim SY; de Melo AC; Kasi A
Acta Oncol; 2021 Jan; 60(1):13-19. PubMed ID: 33131376
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
Wang B; Huang Y
Oncoimmunology; 2020 Sep; 9(1):1824646. PubMed ID: 33294299
[TBL] [Abstract][Full Text] [Related]
5. Association of active immunotherapy with outcomes in cancer patients with COVID-19: a systematic review and meta-analysis.
Cao C; Gan X; Hu X; Su Y; Zhang Y; Peng X
Aging (Albany NY); 2022 Mar; 14(5):2062-2080. PubMed ID: 35271463
[TBL] [Abstract][Full Text] [Related]
6. The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants.
Wu Q; Luo S; Xie X
BMC Cancer; 2022 Mar; 22(1):241. PubMed ID: 35246063
[TBL] [Abstract][Full Text] [Related]
7. The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis.
Liu H; Yang D; Chen X; Sun Z; Zou Y; Chen C; Sun S
Cancer Med; 2021 Feb; 10(3):1043-1056. PubMed ID: 33381923
[TBL] [Abstract][Full Text] [Related]
8. Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies.
Desai A; Gupta R; Advani S; Ouellette L; Kuderer NM; Lyman GH; Li A
Cancer; 2021 May; 127(9):1459-1468. PubMed ID: 33378122
[TBL] [Abstract][Full Text] [Related]
9. Severity of COVID-19 in patients with lung cancer: evidence and challenges.
Passaro A; Bestvina C; Velez Velez M; Garassino MC; Garon E; Peters S
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737345
[TBL] [Abstract][Full Text] [Related]
10. Effect of antitumor therapy on cancer patients infected by SARS-CoV-2: A systematic review and meta-analysis.
Li P; Li L; Wang S; Liu Y; Li Z; Xia S
Cancer Med; 2021 Mar; 10(5):1644-1655. PubMed ID: 33547886
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis.
Sheng Z; Zhang L; Liu X; Yuan L; Li F; Dai D; Wu S; Yang J
Medicine (Baltimore); 2020 Jul; 99(31):e21487. PubMed ID: 32756178
[TBL] [Abstract][Full Text] [Related]
12. Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
Lin Z; Chen J; Han S
Expert Rev Anticancer Ther; 2021 Sep; 21(9):1055-1066. PubMed ID: 33970745
[No Abstract] [Full Text] [Related]
13. Nonsurgical management of resectable oral cavity cancer in the wake of COVID-19: A rapid review and meta-analysis.
Forner D; Noel CW; Wu V; Parmar A; Chan KKW; de Almeida JR; Husain Z; Eskander A
Oral Oncol; 2020 Oct; 109():104849. PubMed ID: 32599499
[TBL] [Abstract][Full Text] [Related]
14. Challenges of cancer immunotherapy and chemotherapy during the COVID-19 pandemic.
Fathi M; Vakili K; Jazi K; Sadeghi MA; Hajiesmaeili M; Mohamadkhani A; Rezaei-Tavirani M; Tavasol A
Tumori; 2022 Oct; 108(5):407-419. PubMed ID: 34918602
[TBL] [Abstract][Full Text] [Related]
15. Preinfection laboratory parameters may predict COVID-19 severity in tumor patients.
Kiani A; Roesch R; Wendtner CM; Kullmann F; Kubin T; Südhoff T; Augustin M; Schaich M; Müller-Naendrup C; Illerhaus G; Hartmann F; Hebart H; Seggewiss-Bernhardt R; Bentz M; Späth-Schwalbe E; Reimer P; Kaiser U; Kapp M; Graeven U; Chemnitz JM; Baesecke J; Lambertz H; Naumann R
Cancer Med; 2021 Jul; 10(13):4424-4436. PubMed ID: 34121360
[TBL] [Abstract][Full Text] [Related]
16. Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.
Madhusoodhan PP; Pierro J; Musante J; Kothari P; Gampel B; Appel B; Levy A; Tal A; Hogan L; Sharma A; Feinberg S; Kahn A; Pinchinat A; Bhatla T; Glasser CL; Satwani P; Raetz EA; Onel K; Carroll WL
Pediatr Blood Cancer; 2021 Mar; 68(3):e28843. PubMed ID: 33338306
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.
Alqahtani JS; Oyelade T; Aldhahir AM; Alghamdi SM; Almehmadi M; Alqahtani AS; Quaderi S; Mandal S; Hurst JR
PLoS One; 2020; 15(5):e0233147. PubMed ID: 32392262
[TBL] [Abstract][Full Text] [Related]
18. Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer.
Angelis V; Tippu Z; Joshi K; Reis S; Gronthoud F; Fribbens C; Okines A; Stanway S; Cottier E; McGrath S; Watkins D; Noble J; Bhosle J; Gerlinger M; Hamid I; Soliman H; Nenclares P; Jones R; Harrington K; Gennatas S
Eur J Cancer; 2020 Sep; 136():99-106. PubMed ID: 32659475
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for COVID-19 among healthcare workers. A protocol for a systematic review and meta-analysis.
Dzinamarira T; Mhango M; Dzobo M; Ngara B; Chitungo I; Makanda P; Atwine J; Nkambule SJ; Musuka G
PLoS One; 2021; 16(5):e0250958. PubMed ID: 33945546
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
